Pradaxa vs. Eliquis: Comparing Blood Thinners for Clot Prevention
Both Pradaxa (dabigatran) and Eliquis (apixaban) are important medications used to prevent dangerous blood clots, such as those that can cause strokes in people with atrial fibrillation or treat deep vein thrombosis (DVT) and pulmonary embolism (PE). While they both serve a similar purpose, they work in slightly different ways and may have different considerations for patients and caregivers.
Side-by-Side Comparison
| Category | Dabigatran Etexilate Mesylate | Apixaban |
|---|---|---|
| Drug Class | Direct Thrombin Inhibitor (DTI) | Factor Xa Inhibitor (FXaI) |
| Primary Use | Reducing stroke/systemic embolism risk in non-valvular atrial fibrillation (NVAF), treating DVT/PE, and preventing DVT/PE recurrence. | Reducing stroke/systemic embolism risk in NVAF, prophylaxis of DVT/PE after hip/knee replacement surgery, treating DVT/PE, and preventing DVT/PE recurrence. |
| Mechanism of Action | Directly blocks thrombin, a key substance in the blood clotting process, preventing fibrin formation. | Selectively inhibits Factor Xa (FXa), another crucial clotting factor, without requiring antithrombin III. |
| Onset of Action | Rapid (typically within 0.5-2 hours) | Rapid (typically within 1-4 hours) |
| Duration | Around 12-14 hours (requires twice-daily dosing) | Around 12 hours (requires twice-daily dosing) |
| Addiction Risk | None | None |
| Common Side Effects | Bleeding (including gastrointestinal bleeding), indigestion, stomach pain, heartburn. | Bleeding (including nosebleeds, bruising), nausea. |
| Cost (Generic) | Generic dabigatran is available, potentially lowering costs. | Generic apixaban is available, potentially lowering costs. |
| When to Choose | May be considered if a direct thrombin inhibitor is preferred or if specific interactions with Factor Xa inhibitors are a concern. | Often chosen for its broad indications, including post-surgical DVT prevention, and generally favorable bleeding profile in some patient populations. |
Bottom Line
Both Pradaxa and Eliquis are effective blood thinners for preventing stroke in atrial fibrillation and treating DVT/PE, but they work through different mechanisms. Your doctor will consider your specific medical history, kidney function, other medications, and potential side effects to determine which medication is best suited for you.
Dabigatran Etexilate Mesylate Overview
Dabigatran (Pradaxa) is a medication that helps prevent blood clots from forming in your body. It works by directly blocking a substance called thrombin, which is essential for blood clotting. This medicine is primarily used to reduce the risk of stroke in people with a type of irregular heartbeat called atrial fibrillation, and to treat or prevent deep vein clots (DVT) and lung clots (PE) in certain situations.
Full Dabigatran Etexilate Mesylate guide →Apixaban Overview
Eliquis (apixaban) is a blood thinner medication used to help prevent harmful blood clots from forming in your body. It works by blocking a specific clotting factor, which reduces your risk of stroke if you have an irregular heartbeat (atrial fibrillation), or helps prevent and treat clots in your legs (DVT) and lungs (PE), especially after certain surgeries.
Full Apixaban guide →Compare prices for Dabigatran Etexilate Mesylate and Apixaban
Check real-time pharmacy prices before you fill — free, no account needed.
Medical Disclaimer
The information on RxGuide is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.